Correlation Between LQwD FinTech and Helix BioPharma
Can any of the company-specific risk be diversified away by investing in both LQwD FinTech and Helix BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LQwD FinTech and Helix BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LQwD FinTech Corp and Helix BioPharma Corp, you can compare the effects of market volatilities on LQwD FinTech and Helix BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LQwD FinTech with a short position of Helix BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of LQwD FinTech and Helix BioPharma.
Diversification Opportunities for LQwD FinTech and Helix BioPharma
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between LQwD and Helix is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding LQwD FinTech Corp and Helix BioPharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helix BioPharma Corp and LQwD FinTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LQwD FinTech Corp are associated (or correlated) with Helix BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helix BioPharma Corp has no effect on the direction of LQwD FinTech i.e., LQwD FinTech and Helix BioPharma go up and down completely randomly.
Pair Corralation between LQwD FinTech and Helix BioPharma
Assuming the 90 days trading horizon LQwD FinTech Corp is expected to generate 1.98 times more return on investment than Helix BioPharma. However, LQwD FinTech is 1.98 times more volatile than Helix BioPharma Corp. It trades about 0.06 of its potential returns per unit of risk. Helix BioPharma Corp is currently generating about -0.03 per unit of risk. If you would invest 223.00 in LQwD FinTech Corp on October 23, 2024 and sell it today you would earn a total of 7.00 from holding LQwD FinTech Corp or generate 3.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 94.74% |
Values | Daily Returns |
LQwD FinTech Corp vs. Helix BioPharma Corp
Performance |
Timeline |
LQwD FinTech Corp |
Helix BioPharma Corp |
LQwD FinTech and Helix BioPharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with LQwD FinTech and Helix BioPharma
The main advantage of trading using opposite LQwD FinTech and Helix BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LQwD FinTech position performs unexpectedly, Helix BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will offset losses from the drop in Helix BioPharma's long position.The idea behind LQwD FinTech Corp and Helix BioPharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Helix BioPharma vs. Microbix Biosystems | Helix BioPharma vs. Oncolytics Biotech | Helix BioPharma vs. Spectral Med | Helix BioPharma vs. Theratechnologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |